Evidence map›Paper›PMID 27143995›Full record

ArticleOxidative medicine and cellular longevity2016

Hepatocyte Growth Factor Reduces Free Cholesterol-Mediated Lipotoxicity in Primary Hepatocytes by Countering Oxidative Stress.

Mayra Domínguez-Pérez, Natalia Nuño-Lámbarri, Denise Clavijo-Cornejo, Armando Luna-López, Verónica Souza, Leticia Bucio, Roxana U Miranda, Linda Muñoz, Luis Enrique Gomez-Quiroz, Salvador Uribe-Carvajal and 1 more

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Mayra Domínguez-PérezPosgrado en Biología Experimental, DCBS, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Departamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico.
Natalia Nuño-LámbarriPosgrado en Biología Experimental, DCBS, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Departamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Unidad de Medicina Traslacional, Clínica y Fundación Médica Sur, 14050 México, DF, Mexico.
Denise Clavijo-CornejoDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Laboratorio de Sinovioanálisis, Instituto Nacional de Rehabilitación, 14389 México, DF, Mexico.
Armando Luna-LópezInstituto Nacional de Geriatría, Secretaria de Salud, 10200 México, DF, Mexico.
Verónica SouzaDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Red Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, 09340 México, DF, Mexico.
Leticia BucioDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Red Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, 09340 México, DF, Mexico.
Roxana U MirandaDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Red Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, 09340 México, DF, Mexico.
Linda MuñozRed Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, 09340 México, DF, Mexico; Unidad de Hígado "Dr. José E González", Hospital Universitario, UANL, 66450 Monterrey, NL, Mexico.
Luis Enrique Gomez-QuirozDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Red Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, 09340 México, DF, Mexico.
Salvador Uribe-CarvajalDepartamento de Genética Molecular, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, 04510 México, DF, Mexico.
María Concepción Gutiérrez-RuizDepartamento de Ciencias de la Salud, Universidad Autónoma Metropolitana Iztapalapa, 09340 México, DF, Mexico; Red Fisiopatología de las Enfermedades Hepáticas, PRODEP-SEP, 09340 México, DF, Mexico.
Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas · ESUniversidad Autónoma Metropolitana · MXInstituto Nacional de Pediatria · MXInstituto Nacional de Rehabilitación · MXUniversidad Nacional Autónoma de México · MX

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cholesterol overload in the liver has shown toxic effects by inducing the aggravation of nonalcoholic fatty liver disease to steatohepatitis and sensitizing to damage. Although the mechanism of damage is complex, it has been demonstrated that oxidative stress plays a prominent role in the process. In addition, we have proved that hepatocyte growth factor induces an antioxidant response in hepatic cells; in the present work we aimed to figure out the protective effect of this growth factor in hepatocytes overloaded with free cholesterol. Hepatocytes from mice fed with a high-cholesterol diet were treated or not with HGF, reactive oxygen species present in cholesterol overloaded hepatocytes significantly decreased, and this effect was particularly associated with the increase in glutathione and related enzymes, such as γ-gamma glutamyl cysteine synthetase, GSH peroxidase, and GSH-S-transferase. Our data clearly indicate that HGF displays an antioxidant response by inducing the glutathione-related protection system.

Indexed as

AnimalsAntioxidantsCase-Control StudiesCells, CulturedCholesterolDietEnzyme-Linked Immunosorbent AssayGlutathioneHepatocyte Growth FactorHepatocytesHumansLiverMaleMiceNon-alcoholic Fatty Liver DiseaseOxidative StressAntioxidantsCholesterolGlutathioneHepatocyte Growth FactorProto-Oncogene Proteins c-metReactive Oxygen Species

Identifiers

PMID27143995
PMCPMC4842075
OpenAlexW2319218769

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.